HNSCC cell lines with low EREG expression are more sensitive to SHP099 than those with high EREG expression, and treatment with exogenous EREG sustains MEK/ERK and PI3K/AKT signaling and confers resistance to SHP099 in EREG-low HNSCC cells [123]. This evidence concerns the gene EREG and head and neck squamous cell carcinoma.